Hexamethylene bisacetamide as a treatment for T-cell leukemia (T-ALL)

Leuk Res. 2008 May;32(5):689-90. doi: 10.1016/j.leukres.2007.11.018. Epub 2007 Dec 31.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy*
  • Leukemia-Lymphoma, Adult T-Cell / pathology

Substances

  • Acetamides
  • Antineoplastic Agents
  • hexamethylene bisacetamide